Developer Docs

BPIQ API + MCP Documentation

Integrate biotech market intelligence, catalyst timelines, and premium MCP agent workflows directly into your product.

Base URL

https://api.bpiq.com/api/v1/info

Get API Key View MCP ServerProduction-ready docsFast integration

Authentication

Send your API key in the `Authorization` header using token auth.

Authorization: Token YOUR_BPIQ_API_KEY

cURL Example

curl -X GET "https://api.bpiq.com/api/v1/info/drugs?ticker=AMRX&has_catalyst=true&limit=30" \
  -H "Authorization: Token YOUR_BPIQ_API_KEY" \
  -H "Accept: application/json"

Endpoints

Core resources and example payloads.

GET/drugs

Drugs

Retrieve drug-level records with linked company, indications, stage/event metadata, and catalyst attributes.

Query Parameters

limitoffsetticker__icontainstickermarket_cap_minmarket_cap_maxcatalyst_date_mincatalyst_date_maxhas_catalystbig_moversuspected_movermoveris_hedge_fund_pickis_hedge_fund_avoidis_high_mgmt_interest

Sample Response

{
  "count": 532,
  "next": "https://api.bpiq.com/api/v1/info/catalysts/?limit=30&offset=30",
  "previous": null,
  "results": [
    {
      "id": 272,
      "company": {
        "ticker": "AMRX",
        "name": "Amneal Pharmaceuticals Inc.",
        "last_price": "14.49",
        "market_cap": 4558262272
      },
      "ticker": "AMRX",
      "drug_name": "Denosumab Biosimilars",
      "indications": [
        {
          "id": 808,
          "title": "Osteoporosis",
          "nickname": ""
        }
      ],
      "indications_text": "Osteoporosis",
      "stage_event": {
        "id": 47,
        "label": "Approved Quarterly sales",
        "stage_label": "Approved",
        "event_label": "Quarterly sales"
      },
      "note": "Denosumab biosimilar candidates reference Prolia(R) and XGEVA(R). 3/4/25- BLA accepted. PDUFA target action date Q4 2025. 8/7/25- Ongoing development. 12/22/25:- FDA approved Boncresa and Oziltus denosumab biosimilars. Prolia/XGEVA U.S. sales ~$5.3B annually.",
      "catalyst_date": null,
      "has_catalyst": true,
      "catalyst_source": "https://www.globenewswire.com/news-release/2025/12/22/3209543/0/en/Amneal-Announces-FDA-Approval-of-Denosumab-Biosimilars-Referencing-Prolia-and-XGEVA.html",
      "is_big_mover": false,
      "is_suspected_mover": false,
      "is_hedge_fund_pick": false,
      "is_hedge_fund_avoid": false,
      "is_high_mgmt_interest": false
    }
  ]
}

Response Fields (/drugs)(Show)

Field	Type	Description
count	integer	Total number of records matching current filters.
next	string \| null	URL for the next paginated page.
previous	string \| null	URL for the previous paginated page.
results	array<object>	Current page of drug records.
results[].id	integer	Unique drug record ID.
results[].company	object	Linked company summary for the drug.
results[].company.ticker	string	Company stock ticker symbol.
results[].company.name	string	Company legal/display name.
results[].company.last_price	string	Latest company share price.
results[].company.market_cap	integer	Company market capitalization.
results[].ticker	string	Primary ticker associated with the drug.
results[].drug_name	string	Drug or program name.
results[].indications	array<object>	List of mapped indications.
results[].indications[].id	integer	Indication ID.
results[].indications[].title	string	Indication label/title.
results[].indications[].nickname	string	Optional short indication alias.
results[].indications_text	string	Flattened/comma-separated indication text.
results[].stage_event	object	Current stage and event classification.
results[].stage_event.id	integer	Stage-event mapping ID.
results[].stage_event.label	string	Combined stage/event display text.
results[].stage_event.stage_label	string	Stage name (e.g., Approved).
results[].stage_event.event_label	string	Event name within the stage.
results[].note	string	Analyst note and timeline context for the record.
results[].catalyst_date	string (ISO date) \| null	Catalyst date when available.
results[].has_catalyst	boolean	Whether the record has catalyst tracking.
results[].catalyst_source	string (URL) \| null	Source URL for catalyst context.
results[].is_big_mover	boolean	Flag for big-mover categorization.
results[].is_suspected_mover	boolean	Flag for suspected-mover categorization.
results[].is_hedge_fund_pick	boolean	Flag when identified as hedge-fund pick.
results[].is_hedge_fund_avoid	boolean	Flag when identified as hedge-fund avoid.
results[].is_high_mgmt_interest	boolean	Flag for high management interest.

GET/catalysts

Catalysts

Retrieve catalyst-level records with linked company, indications, stage/event metadata, and catalyst attributes.

Query Parameters

limitoffsetticker__icontainstickermarket_cap_minmarket_cap_maxcatalyst_date_mincatalyst_date_maxhas_catalystbig_moversuspected_movermoveris_hedge_fund_pickis_hedge_fund_avoidis_high_mgmt_interest

Sample Response

{
  "count": 532,
  "next": "https://api.bpiq.com/api/v1/info/catalysts/?limit=30&offset=30",
  "previous": null,
  "results": [
    {
      "id": 272,
      "company": {
        "ticker": "AMRX",
        "name": "Amneal Pharmaceuticals Inc.",
        "last_price": "14.49",
        "market_cap": 4558262272
      },
      "ticker": "AMRX",
      "drug_name": "Denosumab Biosimilars",
      "indications": [
        {
          "id": 808,
          "title": "Osteoporosis",
          "nickname": ""
        }
      ],
      "indications_text": "Osteoporosis",
      "stage_event": {
        "id": 47,
        "label": "Approved Quarterly sales",
        "stage_label": "Approved",
        "event_label": "Quarterly sales"
      },
      "note": "Denosumab biosimilar candidates reference Prolia(R) and XGEVA(R). 3/4/25- BLA accepted. PDUFA target action date Q4 2025. 8/7/25- Ongoing development. 12/22/25:- FDA approved Boncresa and Oziltus denosumab biosimilars. Prolia/XGEVA U.S. sales ~$5.3B annually.",
      "catalyst_date": null,
      "has_catalyst": true,
      "catalyst_source": "https://www.globenewswire.com/news-release/2025/12/22/3209543/0/en/Amneal-Announces-FDA-Approval-of-Denosumab-Biosimilars-Referencing-Prolia-and-XGEVA.html",
      "is_big_mover": false,
      "is_suspected_mover": false,
      "is_hedge_fund_pick": false,
      "is_hedge_fund_avoid": false,
      "is_high_mgmt_interest": false
    }
  ]
}

Response Fields (/catalysts)(Show)

Field	Type	Description
count	integer	Total number of records matching current filters.
next	string \| null	URL for the next paginated page.
previous	string \| null	URL for the previous paginated page.
results	array<object>	Current page of drug records.
results[].id	integer	Unique drug record ID.
results[].company	object	Linked company summary for the drug.
results[].company.ticker	string	Company stock ticker symbol.
results[].company.name	string	Company legal/display name.
results[].company.last_price	string	Latest company share price.
results[].company.market_cap	integer	Company market capitalization.
results[].ticker	string	Primary ticker associated with the drug.
results[].drug_name	string	Drug or program name.
results[].indications	array<object>	List of mapped indications.
results[].indications[].id	integer	Indication ID.
results[].indications[].title	string	Indication label/title.
results[].indications[].nickname	string	Optional short indication alias.
results[].indications_text	string	Flattened/comma-separated indication text.
results[].stage_event	object	Current stage and event classification.
results[].stage_event.id	integer	Stage-event mapping ID.
results[].stage_event.label	string	Combined stage/event display text.
results[].stage_event.stage_label	string	Stage name (e.g., Approved).
results[].stage_event.event_label	string	Event name within the stage.
results[].note	string	Analyst note and timeline context for the record.
results[].catalyst_date	string (ISO date) \| null	Catalyst date when available.
results[].has_catalyst	boolean	Whether the record has catalyst tracking.
results[].catalyst_source	string (URL) \| null	Source URL for catalyst context.
results[].is_big_mover	boolean	Flag for big-mover categorization.
results[].is_suspected_mover	boolean	Flag for suspected-mover categorization.
results[].is_hedge_fund_pick	boolean	Flag when identified as hedge-fund pick.
results[].is_hedge_fund_avoid	boolean	Flag when identified as hedge-fund avoid.
results[].is_high_mgmt_interest	boolean	Flag for high management interest.

GET/clinical-trialsPremium

Clinical Trials

Retrieve clinical trial records for a given ticker, including study metadata, interventions, conditions, phases, sponsors, and status. The `ticker` parameter is required and requests without it are rejected.

Access restricted to paid plans.

Query Parameters

tickerlimitoffset

Sample Response

{
  "count": 35,
  "data": [
    {
      "_id": "NCT07398417",
      "acronym": "FORWARD",
      "brief_summary": "The study is a Phase 3, double-blind, placebo-controlled, randomized withdrawal study to assess the efficacy and safety of AXS-14 in the management of fibromyalgia.",
      "conditions_list": [
        "Fibromyalgia"
      ],
      "first_posted_date": "2026-02-09 00:00:00",
      "in_airtable": true,
      "intereventions_list": [
        {
          "intervention_name": "AXS-14 (Esreboxetine)",
          "intervention_type": "DRUG"
        },
        {
          "intervention_name": "Placebo",
          "intervention_type": "DRUG"
        }
      ],
      "last_script_update": "2026-03-03 09:38:14.579000",
      "last_updated_date": "2026-02-09 00:00:00",
      "mapped_conditions_list": [
        {
          "condition_name": "Fibromyalgia",
          "disease_areas": [
            "Musculoskeletal Diseases",
            "Nervous System Diseases",
            "Inflammatory disorders"
          ]
        }
      ],
      "meta": {
        "count": {
          "total": 35
        }
      },
      "nctid": "NCT07398417",
      "phases_list": [
        "PHASE3"
      ],
      "primary_completion_date": "2028-03-01 00:00:00",
      "sponsors_list": [
        {
          "name": "Axsome Therapeutics, Inc.",
          "ticker": "AXSM",
          "class": "INDUSTRY",
          "ipo_status": "Public",
          "website": "https://www.axsome.com/"
        }
      ],
      "status": "RECRUITING",
      "study_url": "https://clinicaltrials.gov/study/NCT07398417",
      "tags": [],
      "title": "A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Assess the Efficacy and Safety of AXS-14 in the Management of Fibromyalgia"
    }
  ]
}

Response Fields (/clinical-trials)(Show)

Field	Type	Description
count	integer	Total number of clinical trial records for the ticker.
data	array<object>	Clinical trial records.
data[]._id	string	Clinical trial identifier (typically NCT ID).
data[].acronym	string \| null	Study acronym if available.
data[].brief_summary	string	Brief trial summary/abstract.
data[].conditions_list	array<string>	Conditions targeted by the study.
data[].first_posted_date	string (datetime)	Initial posting date.
data[].in_airtable	boolean	Internal ingestion/source flag.
data[].intereventions_list	array<object>	Study interventions (as returned by API).
data[].intereventions_list[].intervention_name	string	Intervention name (e.g., drug/placebo).
data[].intereventions_list[].intervention_type	string	Intervention type (e.g., DRUG).
data[].last_script_update	string (datetime)	Last pipeline/script refresh timestamp.
data[].last_updated_date	string (datetime)	Last updated date from the source.
data[].mapped_conditions_list	array<object>	Mapped condition taxonomy metadata.
data[].mapped_conditions_list[].condition_name	string	Normalized condition label.
data[].mapped_conditions_list[].disease_areas	array<string>	Disease areas mapped to the condition.
data[].meta	object	Per-record metadata object.
data[].meta.count	object	Record count metadata.
data[].meta.count.total	integer	Total clinical trial count for the request.
data[].nctid	string	ClinicalTrials.gov NCT identifier.
data[].phases_list	array<string>	Study phases (e.g., PHASE3).
data[].primary_completion_date	string (datetime) \| null	Primary completion date when available.
data[].sponsors_list	array<object>	Sponsor/company records associated with the study.
data[].sponsors_list[].name	string	Sponsor company name.
data[].sponsors_list[].ticker	string \| null	Sponsor ticker symbol when mapped.
data[].sponsors_list[].class	string \| null	Sponsor class (e.g., INDUSTRY).
data[].sponsors_list[].ipo_status	string \| null	Sponsor IPO/public status.
data[].sponsors_list[].website	string (URL) \| null	Sponsor website URL.
data[].status	string	Current trial status (e.g., RECRUITING).
data[].study_url	string (URL)	ClinicalTrials.gov study page URL.
data[].tags	array<string>	Optional tags list for the trial record.
data[].title	string	Full study title.

GET/hedge-fund-holdingsPremium

Hedge Fund Holdings

Retrieve hedge funds holding a ticker based on filing data. The `ticker` parameter is required and requests without it are rejected.

Access restricted to paid plans.

Query Parameters

ticker

Sample Response

[
  {
    "id": 60855,
    "company": {
      "id": 337,
      "ticker": "AXSM",
      "name": "Axsome Therapeutics Inc."
    },
    "fund_name": "RTW INVESTMENTS, LP",
    "filing_date": "2026-02-17",
    "value": 162184000,
    "num_shares": 888001,
    "class_title": "COM",
    "name_of_issuer": "AXSOME THERAPEUTICS INC",
    "filing": 541
  },
  {
    "id": 63000,
    "company": {
      "id": 337,
      "ticker": "AXSM",
      "name": "Axsome Therapeutics Inc."
    },
    "fund_name": "PERCEPTIVE ADVISORS LLC",
    "filing_date": "2026-02-17",
    "value": 27195000,
    "num_shares": 148900,
    "class_title": "COM",
    "name_of_issuer": "AXSOME THERAPEUTICS INC",
    "filing": 555
  }
]

Response Fields (/hedge-fund-holdings)(Show)

Field	Type	Description
response	array<object>	List of hedge fund holding records for the ticker.
[].id	integer	Unique holding record ID.
[].company	object	Company reference for the holding.
[].company.id	integer	Internal company ID.
[].company.ticker	string	Ticker symbol for the issuer.
[].company.name	string	Company name.
[].fund_name	string	Reporting hedge fund/manager name.
[].filing_date	string (ISO date)	Filing date associated with the position.
[].value	integer	Reported position value from filing data.
[].num_shares	integer	Number of shares held per filing.
[].class_title	string	Security class title (e.g., COM).
[].name_of_issuer	string	Issuer name in filing records.
[].filing	integer	Filing identifier.

GET/historical-catalystsPremium

Historical Catalysts

Retrieve historical catalyst records with company linkage, timing metadata, and price reaction context.

Access restricted to paid plans.

Query Parameters

limitoffsettickerstagecatalyst_date_mincatalyst_date_max

Sample Response

{
  "count": 6631,
  "next": "https://api.bpiq.com/api/v1/info/historical-catalysts/?limit=30&offset=0",
  "previous": null,
  "results": [
    {
      "id": 6406,
      "company": {
        "id": 454,
        "ticker": "PTGX",
        "name": "Protagonist Therapeutics "
      },
      "created_at": "2026-01-06T13:04:07.375336Z",
      "updated_at": "2026-02-27T13:04:46.865717Z",
      "ticker": "PTGX",
      "drug_name": "Rusfertide",
      "drug_indication": "Polycythemia Vera",
      "airtable_id": 6729,
      "stage": "NDA Filing",
      "catalyst_date": null,
      "catalyst_source": "https://www.businesswire.com/news/home/20260101831438/en/Takeda-and-Protagonist-Announce-Submission-of-New-Drug-Application-NDA-for-Rusfertide-for-Treatment-of-Polycythemia-Vera-PV",
      "catalyst_text": "Submitted FDA NDA for polycythemia vera treatment",
      "detailed_catalyst_text": "An NDA was submitted to the U.S. FDA seeking approval of rusfertide for adults with polycythemia vera. The filing follows positive Phase 3 VERIFY results and supports advancement into regulatory review for a potential new treatment option that may reduce phlebotomy burden and improve hematocrit control.",
      "catalyst_text_evidence": "Takeda and Protagonist Therapeutics announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval of rusfertide for the treatment of adults with polycythemia vera (PV). This NDA submission follows the positive 32-week primary analysis and 52-week results from the Phase 3 global randomized, placebo-controlled VERIFY study.",
      "news_published_at": "2026-01-06T00:00:00Z",
      "open_price_gap_percent": "0.00402",
      "intra_day_price_change_percent": "-0.03827"
    }
  ]
    }

Response Fields (/historical-catalysts)(Show)

Field	Type	Description
count	integer	Total number of records matching current filters.
next	string \| null	URL for the next paginated page.
previous	string \| null	URL for the previous paginated page.
results	array<object>	Current page of historical catalyst records.
results[].id	integer	Unique historical catalyst record ID.
results[].company	object	Linked company summary for this record.
results[].company.id	integer	Company ID.
results[].company.ticker	string	Company stock ticker symbol.
results[].company.name	string	Company legal/display name.
results[].created_at	string (ISO datetime)	Record creation timestamp.
results[].updated_at	string (ISO datetime)	Record last update timestamp.
results[].ticker	string	Primary ticker associated with the catalyst record.
results[].drug_name	string	Drug or program name.
results[].drug_indication	string	Primary indication text for the drug.
results[].airtable_id	integer	Airtable source identifier.
results[].stage	string	Catalyst stage label (e.g., NDA Filing).
results[].catalyst_date	string (ISO date) \| null	Catalyst date when available.
results[].catalyst_source	string (URL) \| null	Source URL for the catalyst update.
results[].catalyst_text	string	Short catalyst summary.
results[].detailed_catalyst_text	string	Expanded catalyst narrative and context.
results[].catalyst_text_evidence	string	Quoted/derived evidence behind catalyst text.
results[].news_published_at	string (ISO datetime)	Timestamp of source news publication.
results[].open_price_gap_percent	string	Open price gap percentage value.
results[].intra_day_price_change_percent	string	Intraday price change percentage value.

Error Reference

Status	Meaning	Notes
400	Bad Request	Invalid query params or date range.
401	Unauthorized	Missing or invalid API key.
403	Forbidden	Your plan does not include this endpoint.
404	Not Found	Resource was not found.
500	Server Error	Unexpected server-side error.

Premium

BPIQ MCP Server

Unlock the MCP server to connect AI agents directly to BPIQ intelligence for company, catalyst, trial, options, and transcript workflows.

Premium access only. Available on paid plans.

MCP Endpoint

https://mcp.bpiq.com/mcp

Authorization Header

Authorization: Token YOUR_BPIQ_API_KEY

MCP Tool	Description
fetch_company_drugs	Fetch normalized drug and catalyst data for a ticker.
fetch_company_info	Fetch company-level profile and financial data (excluding drugs).
fetch_company_hedge_fund_holdings	Fetch hedge fund holdings grouped by filing quarter.
fetch_company_insider_transactions	Fetch insider transactions for recent filing quarters.
fetch_company_clinical_trials	Fetch flattened clinical trial records for a ticker.
fetch_clinical_trial_details	Fetch full ClinicalTrials.gov protocol details by NCT ID.
fetch_company_historical_catalysts	Fetch historical catalyst events for a ticker.
fetch_company_earnings_transcript	Fetch earnings call transcript entries with sentiment.
fetch_company_options_data	Fetch simplified options chain data grouped by expiration.
fetch_company_press_releases	Fetch simplified historical company press releases.

Upgrade For MCP AccessGet your API key and premium MCP access to run production agent workflows.